Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-014515

Chief Accounting Officer acquired 2,822 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2023-06-01 Grant or award +1,411 $22.97 $32,411 3,721 D
Lyon Joseph Douglas Chief Accounting Officer 2023-06-01 Grant or award +1,411 5,132 D
Loading xslF345X04/doc4.xml…